2024年乙肝办健康证政策重大调整：消除歧视与促进社会公平的关键进展
In 2024, China implemented a significant policy adjustment regarding hepatitis B carriers applying for health certificates, marking a crucial step toward eliminating discrimination and promoting social equity. Under the revised regulations, individuals who are hepatitis B virus (HBV) carriers are no longer required to undergo mandatory HBV screening when applying for health certificates for employment, education, or public service positions—unless the specific job poses a high risk of transmission. This reform reflects a science-based approach that prioritizes public health safety while safeguarding the rights of millions affected by hepatitis B.
The updated policy underscores the government’s commitment to aligning with World Health Organization (WHO) guidelines, which emphasize that hepatitis B should not be a barrier to employment or social participation, as it is primarily transmitted through blood, sexual contact, or from mother to child—not through casual daily interaction. By removing outdated restrictions, the new regulation helps dismantle long-standing stigma and misconceptions surrounding the disease, fostering a more inclusive society.
Public health experts have welcomed the change, noting that previous requirements often led to unjust exclusion of qualified individuals from jobs in the food service, education, and healthcare sectors, despite lacking medical justification. The 2024 reform not only protects personal privacy but also encourages more people to seek testing and treatment without fear of discrimination.
As part of broader efforts to promote health equity, authorities have also launched public awareness campaigns to educate employers and the general public about hepatitis B transmission and prevention. These initiatives aim to replace prejudice with understanding, ensuring that health policies are guided by evidence rather than fear.
The 2024 hepatitis B health certificate policy adjustment represents a landmark advancement in human rights and public health in China—one that balances medical responsibility with social justice and sets a precedent for future reforms in health-related legislation.